Coherent Biopharma
PrivateLast Round
Series B
May 23, 2023
Total Funding Raised
$128M
Company Overview
Coherent Biopharma operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series B round in May 2023.
Coherent Biopharma is a clinical-stage biopharmaceutical company that develops bispecific-targeting ligand drug conjugates (Bi-XDC) for the treatment of cancer and other chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Coherent Biopharma Comparables
Compare Coherent Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cybrexa Therapeutics | 82% | |
| Bicycle Therapeutics | 81% | |
| Canwell Biotech Ltd. | 77% |
For institutional investors. Book with your work email.
Coherent Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 23, 2023 | ||||
| Series A Extension | Oct 10, 2018 |
For institutional investors. Book with your work email.
Coherent Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agricultural Bank of China International | Series B |
| Hefei Industry Investment Group | Series B |
| 6 Dimensions Capital | Series A Extension |
| Hefei Hi-Tech VC | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2023
$100M round with Agricultural Bank of China International and Hefei Hi-Tech VC.
- Oct 10, 2018
$20M round led by 6 Dimensions Capital
For institutional investors. Book with your work email.
Coherent Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Coherent Biopharma's valuation, stock price, and market status.
Is Coherent Biopharma a public or private company?
Coherent Biopharma is a private company.
What is the current stock price of Coherent Biopharma?
Coherent Biopharma is a private company, so its shares have no public market price. Caplight tracks Coherent Biopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Coherent Biopharma worth (valuation)?
Valuation information for Coherent Biopharma is not publicly available.
Can I buy Coherent Biopharma stock?
Coherent Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Coherent Biopharma's last funding round?
Coherent Biopharma's most recent funding round was Series B on May 23, 2023.
Who are the main investors in Coherent Biopharma?
Key investors in Coherent Biopharma include 6 Dimensions Capital.
Will Coherent Biopharma IPO soon?
No public IPO plans have been announced for Coherent Biopharma.
How can I track Coherent Biopharma secondary market activity?
Caplight tracks bids, offers, and trades in Coherent Biopharma's shares on secondary markets.